Key result
Nearly ~30% of new postoperative SWI lesions disappear over time after flow diverter treatment.
Why the study?
Little is known about how newly observed SWI lesions change over time following endovascular surgery, specifically after flow diverter treatment for cerebral aneurysms.
Cohort (n=73)
Nearly 30% of new susceptibility-weighted imaging (SWI) lesions appearing after flow diverter treatment for cerebral aneurysms disappear over time—mostly within 1 month and predominantly in the white matter—behaving differently from conventional cerebral microbleeds.
Answers are grounded in this paper and cite their sources.
New SWI lesions after FD may resolve on serial MRI; leaves open their clinical significance in cerebral aneurysm patients.
BACKGROUND AND PURPOSE: Little is known about changes over time for SWI lesions newly observed following endovascular surgery. This study was aimed to introduce disappearance of postoperative new SWI lesions after flow diverter (FD) treatment for cerebral aneurysms with serial MRI scans. MATERIALS AND METHODS: In this retrospective observational study, patients who underwent FD treatment for cerebral aneurysms between December 2017 and June 2024 were analyzed. The patients received dual antiplatelet therapy at least 2 weeks before the treatment to obtain appropriate inhibition of platelet aggregation. Systemic heparinization was introduced during the FD deployment to maintain activated clotting time more than 250 sec. MRI including SWI were routinely obtained preoperatively (1 to 3 days before the FD treatment), postoperative day 1 and 1, 3, 6, and 12 months after the surgery. By comparing the preoperative MRI with those obtained postoperative day 1, new lesions in SWI that appeared in the FD-treated vascular territory were detected. Their locations were divided into gray matter supplied by cortical arteries (cortex), white matter and gray matter supplied by perforators (deep nucleus such as basal ganglia, thalamus, and dentate nucleus). The new SWI lesions had been monitored with follow-up MRI for their changes over time and determined whether they disappeared or not. RESULTS: Seventy-six aneurysms from 73 patients were included. Mean age was 65.2 ± 13.6 years old and 55 (75.3%) were female. On postoperative day 1, 525 new SWI lesions (median number 5 [0-64]) were detected in 67 patients. Of these, 263 (50.1%) were located in the cortex, 244 (46.5%) were in the white matter, and 18 (3.4%) were in the deep nucleus. Of the 525 lesions, 157 (29.9%) in 48 patients were disappeared over time. There were significantly more disappearing lesions in the white matter (125) compared with the other territories (the cortex 26 and the deep nucleus 6) (p < 0.001). Ninety-nine lesions (63.1%) disappeared within 1 month after the FD treatment. CONCLUSIONS: Some of new SWI lesions after FD treatments, especially in the white matter, disappeared. These behaviors were different from those of conventional microbleeds.
No takes yet. Share an insight, caveat, or question.
Yasuda et al. (2026) conducted a cohort in Cerebral aneurysms (n=73). Flow diverter treatment for cerebral aneurysms was evaluated on Disappearance of postoperative new susceptibility-weighted imaging (SWI) lesions over time on follow-up MRI (p=< 0.001). Flow diverter treatment resulted in 525 new postoperative SWI lesions, of which 29.9% disappeared over time, occurring more frequently in white matter than other territories.
Synapse has enriched 10 related papers. Consider them for comparative context: